ADAM9 and neoplasm: Directly binding to platelet α6β1, a disintegrin and a metalloprotease 9 (ADAM9) was identified as the major receptor of α6β1 and this interaction efficiently promoted platelet activation, tumor cell extravasation, and lung metastasis [85].